I K Schwartz, C C Campbell. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antimalarials/therapeutic useDrug Combinations/therapeutic useDrug LabelingHumansMalaria/prevention & controlPyrimethamine/therapeutic useSulfadoxine/therapeutic useSulfanilamides/therapeutic use
Substances： See more » AntimalarialsDrug CombinationsSulfanilamidesfanasil, pyrimethamine drug combinationSulfadoxinePyrimethamine
Year: 1982 PMID： 7088068 DOI： 10.1056/NEJM198207153070330
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245